New Treatment Option for Advanced Liver Cancer Tops SPT Week in Review


Top news of the week from Specialty Pharmacy Times.

5. FDA Grants Breakthrough Designation to Mantle Cell Lymphoma Treatment

Zanubrutinib (BGB-3111) is being investigated for the treatment of various B-cell malignancies, including mantle cell lymphoma. Read more.

4. House Committee Investigating Prescription Drug Pricing Practices

The committee is seeking detailed information and documents about some pharmaceutical companies' prescription drug pricing practices. Read more.

3. FDA OKs Generic Vigabatrin Tablets for Seizures

Vigabatrin, which is also sold under the brand name Sabril, is used to treat complex partial seizures in adult and pediatric patients. Read more.

2. Walmart Leaving CVS Pharmacy Networks Over Reimbursement Dispute

Officials with CVS Health have announced that Walmart has opted to leave CVS Caremark pharmacy benefit management commercial and Managed Medicaid retail pharmacy networks. Read more.

1. FDA OKs Cabozantinib for Previously-Treated Hepatocellular Carcinoma

Cabozantinib’s new indication provides an additional therapeutic option for patients with advanced liver cancer who have been previously treated with sorafenib. Read more.

Related Videos
cancer pain management | Image Credits: © Burlingham -
multiple myeloma clinical trial daratumumab/ Image Credits: © Dragana Gordic -
multiple myeloma clinical trial/Image Credits: © Studio Romantic -
3d rendered illustration of lung cancer 3D illustration - Image credit:  appledesign |
pharmacy oncology, Image Credit: © Konstantin Yuganov -
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 -
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder -
© 2024 MJH Life Sciences

All rights reserved.